ArticleFrontiers in immunology2025
Fruquintinib saddles tumor immune tolerance by curbing pro-tumoral immature myeloid cell populations.
Lucía Suárez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it